Revenue | ₹169.52Cr |
Net Profits | ₹4.36Cr |
Net Profit Margins | 2.57% |
Sudarshan Pharma Industries Ltd’s revenue jumped 45.92% since last year same period to ₹169.52Cr in the Q3 2025-2026. On a quarterly growth basis, Sudarshan Pharma Industries Ltd has generated -0.71% fall in its revenue since last 3-months.
Sudarshan Pharma Industries Ltd’s net profit jumped 51.39% since last year same period to ₹4.36Cr in the Q3 2025-2026. On a quarterly growth basis, Sudarshan Pharma Industries Ltd has generated 4.31% jump in its net profits since last 3-months.
Sudarshan Pharma Industries Ltd’s net profit margin jumped 3.74% since last year same period to 2.57% in the Q3 2025-2026. On a quarterly growth basis, Sudarshan Pharma Industries Ltd has generated 5.05% jumped in its net profit margins since last 3-months.
The revenue for Sudarshan Pharma Industries Ltd in the Q3 results 2025 was ₹169.52Cr.
The net profit for Sudarshan Pharma Industries Ltd in the Q3 results 2025 was ₹4.36Cr.
The net profit margin for Sudarshan Pharma Industries Ltd in the Q3 results 2025 was 2.57%.
The revenue for Sudarshan Pharma Industries Ltd in the Q3 results 2024 was ₹116.17Cr.
The net profit for Sudarshan Pharma Industries Ltd in the Q3 results 2024 was ₹2.88Cr.
The net profit margin for Sudarshan Pharma Industries Ltd in the Q3 results 2024 was 2.48%.